Why the study?
Does lysine acetylsalicylate improve the speed of platelet aggregation inhibition compared to aspirin in patients with chronic stable angina?
Does lysine acetylsalicylate improve the speed of platelet aggregation inhibition compared to aspirin in patients with chronic stable angina?
Lysine acetylsalicylate provides significantly faster platelet aggregation inhibition than regular aspirin, which may be beneficial in the acute management of coronary syndromes.
May support faster antiplatelet onset in acute coronary syndromes; extends aspirin formulation data to early inhibition in stable angina.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Gurfinkel et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: